Volume 66, Issue 1, Pages (January 2017)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Lecture # 31 TISSUE REPAIR: REGNERATION, HEALING & FIBROSIS - 3 Dr. Iram Sohail Assistant Professor Pathology College Of Medicine Majmaah University.
Inflammasomes in liver diseases
Angiogenesis and hepatocellular carcinoma
The yin and yang of evasion and immune activation in HCC
New directions for cell-based therapies in acute liver failure
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Liver regeneration Journal of Hepatology
Volume 57, Issue 1, Pages 6-8 (July 2012)
Hedgehog signaling in the liver
The function of serotonin within the liver
Vascular endothelial dysfunction in cirrhosis
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Regulatory T-cell directed therapies in liver diseases
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Liver Renewal: Detecting Misrepair and Optimizing Regeneration
Mechanisms of Hepatic Fibrogenesis
Cell-Based therapy for traumatic brain injury
Marina Berenguer, Detlef Schuppan  Journal of Hepatology 
Figure 4 Macrophages in liver inflammation
Inflammation and portal hypertension – The undiscovered country
From immunosuppression to tolerance
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Atsushi Miyajima, Minoru Tanaka, Tohru Itoh  Cell Stem Cell 
The quest for liver progenitor cells: A practical point of view
Targeting gut flora to prevent progression of hepatocellular carcinoma
Mechanisms of iron hepatotoxicity
Angiogenesis and hepatocellular carcinoma
Primary biliary cirrhosis: A 2010 update
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
The yin and yang of evasion and immune activation in HCC
Volume 41, Issue 5, Pages (November 2004)
Volume 146, Issue 5, Pages (May 2014)
Approaches for treatment of liver fibrosis in chronic hepatitis C
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
Volume 59, Issue 3, Pages (September 2013)
Sinusoidal communication in liver fibrosis and regeneration
Volume 143, Issue 6, Pages e2 (December 2012)
Yasuko Iwakiri, Vijay Shah, Don C. Rockey  Journal of Hepatology 
Hepatic fibrosis: Concept to treatment
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
Volume 144, Issue 3, Pages (March 2013)
Cannabinoid signaling and liver therapeutics
Liver fibrosis – from bench to bedside
Stefan Frank, Heiko Kämpfer, Christian Wetzler, Josef Pfeilschifter 
Fibrosis in chronic liver diseases: diagnosis and management
Volume 59, Issue 2, Pages (August 2013)
Process and mechanisms of blood vessel formation.
Diarmaid Dominic Houlihan, Philip Noel Newsome  Gastroenterology 
NASH animal models: Are we there yet?
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
Macrophage heterogeneity in liver injury and fibrosis
The dynamic biliary epithelia: Molecules, pathways, and disease
Autophagy in liver diseases: Time for translation?
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
Statins: Old drugs as new therapy for liver diseases?
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
Adel Hammoutene, Pierre-Emmanuel Rautou  Journal of Hepatology 
Molecular pathways underlying angiogenesis.
Volume 70, Issue 6, Pages (September 2006)
Volume 61, Issue 2, Pages (August 2014)
Platelets arrive at the scene of fibrosis……studies
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
O2 Sensing: Only Skin Deep?
Presentation transcript:

Volume 66, Issue 1, Pages 212-227 (January 2017) Liver sinusoidal endothelial cells: Physiology and role in liver diseases  Johanne Poisson, Sara Lemoinne, Chantal Boulanger, François Durand, Richard Moreau, Dominique Valla, Pierre-Emmanuel Rautou  Journal of Hepatology  Volume 66, Issue 1, Pages 212-227 (January 2017) DOI: 10.1016/j.jhep.2016.07.009 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Formation of sinusoids during human embryogenesis. (A) Frontal section of an embryo showing the formation of an outgrowth of the foregut (endoderm), called the liver primordium, which extends into the septum transversum (mesoderm), in which blood vessels are developing. V, ventral; D, dorsal. (B) Transversal section of the embryo showing the liver primordium (i.e., hepatoblasts arranged in thick cords separated by vascular spaces) growing into the septum transversum. The hepatic sinusoids are progressively established. First, the endothelial lining is continuous with a basement membrane (pink region) and no fenestrations. Around gestation week 12, fenestrations appear initially with diaphragms. These diaphragms disappear during development [15,170,171]. Journal of Hepatology 2017 66, 212-227DOI: (10.1016/j.jhep.2016.07.009) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Role of liver sinusoidal cells (LSECs) in chronic liver diseases. In normal conditions, LSECs maintain hepatic stellate cell quiescence through a NO-dependent pathway as long as they are differentiated [101]. Exposure of LSECs to a physiological shear stress activates the transcriptor factor KLF2 leading to the release of vasodilating agents including nitric oxide (NO) and to the downregulation of vasoconstrictive molecules including endothelin-1. In a cirrhotic liver, LSECs become capillarized, meaning that they lose their fenestrae and a basement membrane appears. Capillarized LSECs permit hepatic stellate cell activation and thus production of collagen and of fibrosis. This change is associated with an endothelial dysfunction meaning that increased shear stress no longer leads to vasodilation but rather to vasoconstriction and thus to increased intrahepatic resistance. Simvastatin restores the vasoprotective effect of KLF2 and improves HSC phenotype through a NO-dependent pathway (the effect of simvastatin appears in red) [102]. BM, basement membrane; E, endothelin; HSC, hepatic stellate cell; KLF2, Kruppel-like factor 2; LSEC, liver sinusoidal cell; NO, nitric oxide. Journal of Hepatology 2017 66, 212-227DOI: (10.1016/j.jhep.2016.07.009) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 3 A dual role of VEGF in chronic liver disease progression. In physiological conditions, VEGF released by hepatocytes, cholangiocytes and HSC, maintains LSEC differentiation (blue arrow) and consequently HSC quiescence. VEGF is thus anti-fibrogenic. During fibrogenesis, liver expression of VEGF increases. These high VEGF levels have a pro-fibrogenic action (red arrows) by inducing liver angiogenesis and by activating HSC. The activation of HSC results from a direct action of VEGF on HSC and from the release of TGF-β1 by capillarized LSECs. BM, basement membrane; HSC, hepatic stellate cell; LSEC, liver sinusoidal cell; VEGF, vascular growth factor; TGF-β1, transforming growth factor β1. Journal of Hepatology 2017 66, 212-227DOI: (10.1016/j.jhep.2016.07.009) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Liver sinusoidal cell (LSECs) and liver regeneration following acute liver injury or partial hepatectomy. Following liver injury, liver expression of VEGF increases, leading to the proliferation of bone marrow sinusoidal progenitor cells (SPC) (1), to their mobilization to the circulation (2), their engraftment in the sinusoids (3) and their differentiation in mature LSECs (4). VEGF A stimulates liver regeneration trough LSECs (a) leading to HGF production (b), hepatocyte proliferation (c) and LSECs proliferation (d) [20]. Increased shear stress associated with liver resection induces LSECs derived nitric oxide (NO) (I), which increase the effect of HGF on hepatocytes proliferation (II). Platelets are rapidly recruited in the liver after liver surgery (A). They adhere to LSECs and stimulate secretion of key molecules involved in hepatocytes (F) and LSECs (B) proliferation and survival. Platelets can also be endocytosed by LSECs (C), or trapped in the space of Disse (E), a migration facilitated by the increased size of fenestration associated with liver surgery (D). Abbreviations: HSC, hepatic stellate cell; NO, nitric oxide; LSEC, liver sinusoidal cell; HGF, hepatocyte growth factor; VEGF, vascular growth factor; VEGFR, vascular growth factor receptor; SPC, sinusoid progenitor cells. Journal of Hepatology 2017 66, 212-227DOI: (10.1016/j.jhep.2016.07.009) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions